Back to
CAPSTONE INVESTMENT ADVISORS, LLC
TEVA
Showing 0 of 4 quarters
Position history for
CAPSTONE INVESTMENT ADVISORS, LLC's holdings in TEVA PHARMACEUTICAL INDS LTD
No. Capstone Investment Advisors exited its TEVA (Teva Pharmaceutical Industries) position in Q1 2024. Its Q4 2023 13F listed 12,730 shares worth $132,901. Capstone Investment Advisors first reported TEVA in Q2 2019 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.